BioCentury Real-World Evidence Spotlight Collection

BioCentury Real-World Evidence Spotlight Collection


BioCentury's spotlight on "Real-World Evidence" highlights BioCentury's recent coverage and analysis into the opportunities for Western pharmaceutical companies to accelerate drug development processes in China using the Real World Evidence (RWE) approval pathway.

Return to Whitepapers

Topics Discussed

Included in the collection:

  • Bringing down real-world evidence barriers in China
  • A role for RWE in the accelerated approval pathway
  • Aligning on the advancement of real-world evidence
  • The pivotal role of real-world data in a pandemic

Download the Whitepaper

To download BioCentury Real-World Evidence Spotlight Collection, please click the DOWNLOAD link below.